The new therapy, known as glofitamab or Columvi®, has been approved by both the Medicines and Healthcare Products Regulatory Agency (MHRA) and the National Institute of Health and Care Excellence (NICE…
Read More
New NHS Treatment Offers Hope for Blood Cancer Patients
